Survey Survey on the use of non-cryopreserved hematopoietic stem cells for autologous HSCT in adults Group Infectious Diseases Working Party (IDWP) Transplant Complications Working Party (TCWP) Principal investigator Emilian Snarski
Survey Current Management to Prevent and Treat CD19+ and BCMA+ CAR-T Cell Therapy-Related Complications Group Transplant Complications Working Party (TCWP) Principal investigator Olaf Penack
Daratumumab for PRCA after alloSCT Group Transplant Complications Working Party (TCWP) Type of Stem Cell Treatment Principal investigator Nico Gagelmann
Outcomes of PT-CY in elderly AML/MDS Diseases Group Transplant Complications Working Party (TCWP) Type of Stem Cell Treatment Principal investigator Maria Queralt Salas
Immune Checkpoint Inhibitors for solid tumors after allogeneic stem cell transplanation Diseases Group Transplant Complications Working Party (TCWP) Principal investigator Jan Brijs
Pre-transplantation diabetes and obesity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation Group Transplant Complications Working Party (TCWP) Principal investigator Lars Klingen Gjaerde
Chronic GVHD over time - a multicenter retrospective study Diseases Group Transplant Complications Working Party (TCWP) Principal investigator Drazen Pulanic
Steroid-free first line treatment of moderate and severe chronic GVHD - restrospective study Diseases Group Transplant Complications Working Party (TCWP) Principal investigator Ivan Moiseev
Effects of donor clonal hematopoiesis in unrelated HSCT Diseases Group Transplant Complications Working Party (TCWP) Principal investigator F. Damm & J. Schetelig
Machine learning approach to estimate toxicity-related mortality following allogeneic HSCT Diseases Group Transplant Complications Working Party (TCWP) Principal investigator Alberto Mussetti
Lung GvHD - Review of current practices Study type Diseases Group Transplant Complications Working Party (TCWP) Principal investigator John Murray; Saskia Bos
EBMT patient engagement taskforce (PRO) Diseases Group Transplant Complications Working Party (TCWP) Type of Stem Cell Treatment Principal investigator Helene Schoemans